Capital Advisors Inc’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-58,461
Closed -$9.56M 205
2017
Q4
$9.56M Sell
58,461
-4,328
-7% -$777K 0.56% 61
2017
Q3
$12.9M Buy
62,789
+2,013
+3% +$468K 0.79% 39
2017
Q2
$14.8M Sell
60,776
-1,416
-2% -$333K 0.92% 26
2017
Q1
$14.9M Sell
62,192
-24,628
-28% -$5.74M 0.97% 22
2016
Q4
$18.2M Buy
86,820
+25,447
+41% +$5.27M 1.27% 15
2016
Q3
$14.1M Buy
+61,373
New +$15M 2.11% 5

Other funds holding AGN

Capital Advisors Inc's AGN Position: Q1 2018 in Review

Capital Advisors Inc sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 58,461 shares — an estimated $9.56M sold.

Capital Advisors Inc first reported a position in AGN in Q3 2016 and held it in 6 quarters. The position peaked at $18.2M in Q4 2016. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

  • Capital Advisors Inc reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Capital Advisors Inc sold 58,461 Allergan plc shares in Q1 2018, an estimated $9.56M.
  • Capital Advisors Inc first reported a position in Allergan plc in Q3 2016 and held it in 6 quarters.
  • Capital Advisors Inc's Allergan plc position peaked at $18.2M in Q4 2016.
  • 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Capital Advisors Inc's 13F filing for Q1 2018, filed 4 May 2018.